恒瑞医药

- 600276

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015 
恒瑞医药(600276) 利润表
单位:万元
报表日期2024-09-302024-06-302024-03-312023-12-312023-09-30
一、营业总收入2,018,930.381,360,073.41599,753.392,281,978.471,701,363.22
营业收入2,018,930.381,360,073.41599,753.392,281,978.471,701,363.22
二、营业总成本1,508,997.92975,600.04441,291.621,821,415.251,325,878.67
营业成本283,318.27187,330.3794,284.94352,524.78265,755.41
营业税金及附加17,241.5011,495.165,801.7921,925.7116,273.32
销售费用610,928.78393,821.45176,425.60757,717.59540,855.13
管理费用187,411.17117,399.8557,630.16241,697.45167,591.25
财务费用-44,788.83-38,222.16-14,863.55-47,838.99-37,145.93
研发费用454,887.03303,775.38122,012.69495,388.71372,549.50
资产减值损失----------
公允价值变动收益952.97754.22733.77-5,825.69-3,576.83
投资收益-3,142.04-1,614.0161.59-4,915.68-1,156.57
其中:对联营企业和合营企业的投资收益-5,422.76-3,437.73---7,269.60-4,711.47
汇兑收益----------
三、营业利润534,529.05398,477.61163,600.88490,990.49394,132.95
加:营业外收入579.09313.2619.88379.84243.48
减:营业外支出26,434.1323,630.8613,369.6824,659.3613,138.74
其中:非流动资产处置损失----------
四、利润总额508,674.02375,160.01150,251.08466,710.97381,237.69
减:所得税费用47,041.0032,346.7713,502.2138,928.9036,134.71
五、净利润461,633.02342,813.24136,748.87427,782.07345,102.98
归属于母公司所有者的净利润461,957.59343,174.81136,892.92430,243.59347,377.92
少数股东损益-324.57-361.57-144.06-2,461.52-2,274.93
六、每股收益
基本每股收益(元/股)0.73000.54000.21000.68000.5500
稀释每股收益(元/股)0.73000.54000.21000.68000.5500
七、其他综合收益-1,263.10-1.72-592.541,784.141,400.44
八、综合收益总额460,369.92342,811.51136,156.33429,566.21346,503.42
归属于母公司所有者的综合收益总额460,807.66343,097.53136,278.73431,853.01348,469.65
归属于少数股东的综合收益总额-437.74-286.01-122.40-2,286.79-1,966.24
下载全部历史数据到excel中 返回页顶